Intrinseque Health to invest USD 10M in India

Intrinseque Health announces plans to invest USD 10 million to bolster its clinical supply chain & drug development services in India.

Intrinseque Health, the renowned global leader in clinical supply chain solutions, is thrilled to announce expansion of its Indian operations with enhancement of its existing services and introduction of several new services to its customers. This strategic move marks a significant milestone for the company as it seeks to broaden its horizons and make a positive impact on the global clinical trials landscape in India and globally.

“India has a vibrant and rapidly expanding healthcare ecosystem, and we are enthusiastic about contributing our expertise to support and accelerate clinical research in this region. This expansion will further bolster our vast array of capabilities & services, allowing us to provide & execute robust clinical supply plans to our customers & seeks to support drug development related research initiatives focused on patient well-being and the development of life-changing therapies. Intrinseque Health aims to be the most innovative drug development support organisation, focusing on providing therapeutically aligned, quality-centric, global clinical supply chain solutions”, said Nitin Jain, President & CEO at Intrinseque Health.

“Availability of the best-in-class infrastructure and highly qualified talent in the country has encouraged us to invest and expand further in the region, servicing our customers globally. In addition to our facility in New Delhi, we plan to set up facilities in Bengaluru, Hyderabad & Mumbai in the next 5 years.”, added, Jain. Intrinseque Health